Arrowhead Pharmaceuticals (ARWR) reported fiscal Q1 2024 results and announced a reorganization that will reduce annual expenses by $100 million a year and quarterly operating cash burn down to ...

In today's rapidly evolving business landscape, the quest for sustainable growth is more critical than ever. As someone who has firsthand experience scaling a company sustainably, I have witnessed the ...